Concepedia

Publication | Closed Access

Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis

DOI

85

Citations

24

References

2013

Year

Barbara Kornek, Fahmy Aboul‐Enein, Kevin Rostásy, Ruxandra‐Iulia Milos, Irene Steiner, Johann Penzien, Kerstin Hellwig, Kalliopi Pitarokoili, Karin Storm van’s Gravesande, Michael Karenfort,
JAMA Neurology

Abstract

Our data indicate that natalizumab may be safe and effective against MS in pediatric patients with breakthrough disease.

References

YearCitations

Page 1